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It is now well established that rheumatoid factor (RF)-like anti-IgG autoanti- 
bodies frequently occur in the mouse (1-6). 
The development of RF-secreting hybridomas derived from polyclonally acti- 
vated spleen cells or obtained from animals spontaneously producing RF made 
it possible to study the fine specificity of these autoantibodies. It appeared that, 
whatever their origin, the majority of mouse monoclonal RF were specific for a 
single  IgG  subclass:  most  were  directed against  IgG1  or  IgG2a,  some against 
IgG2b. Competition experiments with heat-aggregated immunoglobulins showed 
that subclass specificity was also characteristic of the polyclonal RF found in the 
serum  of autoimmune strains,  NZB and  MRL/MpJ-lpr  (7).  In addition,  many 
IgG2a-specific  RF  derived  from  BALB/c  (Igh  a)  or  129/Sv  (Igh  a)  mice  also 
displayed aliotype specificity in the sense that they failed to react with IgG2a of 
the "b" allotype. 
To localize the determinants involved in these RF-IgG interactions, we have 
investigated the reactivity of RF, both polyclonal and monoclonal with immu- 
noglobulins carrying abnormal heavy chains (8, 9). 
The results indicate that both the allotypic and isotypic determinants recog- 
nized by mouse RF are  located  in  the C-terminal region of 3'1,  3"2a, and 3"2b 
heavy chains. 
Materials and Methods 
Rheumatoid Factors.  RF-secreting hybridomas were derived from spleen cells of 129/ 
Sv, BALB/c, CBA/Ht, or C57B1/6 mice as described (5, 7). Both cell culture supernatants 
and purified proteins were used as a source of monoclonal RF. RF-containing sera were 
obtained from 20-wk old 129/Sv, MRL/MpJ-Ipr and NZB/BinJ mice. The former were 
maintained in  our colony; the latter two were obtained from The Jackson Laboratory 
(Bar Harbor, ME). 
Protein,s.  Hen egg white lysozyme was purchased from Koch-Light Laboratories Ltd 
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TABLE  I 
Binding* of IgG l-specific Monoclonal RF to IgG1 Mutants and F(ab')z Fragments 
Strains  Monoclonal  RF  MOPC  21' 
Mutant MOPC 21'  Anti-lysozyme  lgGl! 
IF1  IF2  Native  F(ab')~ 
129/Sv  1302G3  31  0  31  28  0 
1312E8  23  2  29  33  0 
1413A3  25  0  30  28  0 
1415D9  13  0  30  33  0 
8816C7  19  0  29  28  0 
8817D7  27  0  33  34  1 
A5701A4  25  0  29  33  0.7 
A7206F3  27  0  30  33  0.4 
B2001A7  23  0  25  34  0 
B2003G5  20  0  23  33  0 
B1202A5  22  23  30  34  0 
BALB/c  B2701Bll  28  0  28  37  0 
C57B1/6  B2806C3  26  0  26  33  0.3 
B2801FI1  27  0  28  35  0 
B2802D1  30  0  29  27  0 
CBA/Ht  A5503D10  20  2  26  19  1 
A5501C3  17  2  29  31  0.4 
* Measured by solid phase RIA as described in (7) and expressed  in cpm x 10  -s after subtraction  of cpm bound to 
wells coated with BSA. The latter never exceeded 10% of the specific  binding. Binding of lgGl-specific RF to 
F(ab')2 fragments was studied with wells coated overnight with lysozyme  (30 #g/ml) and incubated for 2 h at 
37°C with 10 #g/ml monoclonal  lgG1 anti-lysozyme  antibody  (A7202En) or its F(ab')2  fragments. When checked 
with ~I-labeled  affinity-purified  rabbit antibodies  against mouse Fab fragments, the binding of F(ab')~  fragments 
to lysozyme-coated  wells  was found to be equivalent to that of native antibody. 
* Adsorption of proteins onto polyvinyl  wells  was checked with t2~I-labeled  rabbit anti-mouse  Fab antibody. Wells 
incubated with IFI bound approximately two times more anti-Fab antibody than either MOPC21 and IF2. 
Experiments were run in triplicate. 
i Experiments  run in duplicate. 
(Berkshire, U.K.). MPC1 1 (3'2b, K) and variant proteins were purified from ascites fluids 
as described (8). MOPC21 (3' 1, r), MOPC 173 (3'2a, ~), and hybridoma proteins, A7202E 11 
(3'1, K),  1 103G4  (3'2a,  ~),  308A8  (3"2b,  K), and  A7708F11  (3'2a, K) were purified from 
ascites fluid  by  chromatography  on  Protein  A  Sepharose  (Pharmacia  Fine Chemicals, 
Uppsala, Sweden), and mutant proteins IF1 and IF2 were isolated by ammonium sulfate 
precipitation and sucrose gradient ultracentrifugation. A7202E 1 1, an IgG 1 anti-lysozyme 
antibody of 129/Sv origin, was submitted to pepsin digestion (0.1 mg/mg antibody) at pH 
3.6  for  24  h  at  37°C.  F(ab')2 fragments were  purified by chromatography on  AcA44 
Ultrogel (LKB,  Bromma,  Sweden), and  their molecular weight and  purity checked by 
sodium dodecyl suifate-polyacrylamide gel electrophoresis. 
Coating and Agglutination of Polystyrene Particles.  Carboxylated polystyrene particles (0.8 
~m diameter, Rh6ne-Poulenc, Courbevoie, France) were coated with purified monoclonal 
proteins by the carbodiimide method as described (7). 
Results 
Determinants  Recognized  by Monoclonal  IgGl-specific  RF.  We  first  tested  the 
binding  of IgGl-specific  RF  to  F(ab')2  fragments  derived  from  a  monoclonal 
IgG1  anti-lysozyme antibody (A7202E1 1).  Typical results are shown in Table I. 
Each  of  71  monoclonal  anti-IgG1  RF  tested,  strongly  reacted  when  intact 
antibody was complexed to lysozyme but not when  F(ab)'2 fragments were used. 
In  a  second  set  of experiments  we  examined  the  binding  of these  monoclonal 
RF to mutant IgG1 molecules, IF1 and IF2, which are derived from the MOPC21 
cell  line  and  carry  3,1  chains  lacking  the  CH3  and  CH1  domains,  respectively. 
Typical results are given in Table  I. All RF optimally bound  to IF2, whereas  70 
of  71  completely  failed  to  react  with  IF1,  which  strongly  suggests  the  CH3 
location of the  determinants  involved in  these  reactions.  The  RF  that  reacted STASSIN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIGURE  1.  Heavy chain constant region organization of MPC11  and of 3  groups of mutant 
proteins.  ~2b  segments are  denoted  (tz2) and  ?2a  segments  (i).  The  hatched  area  (orn) 
represents a  sequence (N316-339) comprising 24 aminoacids that are identical between ?2a 
and ~'2b chains. The proteins used in the present experiments are indicated. 
TABLE  II 
Reaction of Monoclonal RF with IgG2b Variant Proteins: Agglutination of Polystyrene Particles* 
% Agglutination  of particles coated with: 
IgG2b  Variant IgG2b  Monoclonal  IgG2a 
RF 
1103G4  ICR  ICR  308A8  MPC11  ICR 16  M224  ICR 11.8  11.19.3  4.68.110 
A.ti-lgG2a 
A5701B4  90  0  0  85 
A5705B8  91  0  0  93 
A5705A5  92  0  0  66 
A6507A10  88  5  3  92 
A6504C 12  80  0  4  83 
A6503G8  65  4  0  87 
Anti-lgG2a'* 
A6107G6  90  6  0  89 
A6506G  r  88  4  5  90 
A7105D4  88  0  0  91 
A8601A2  90  0  0  57 
A8603AI 1  91  5  4  51 
A8602B4  91  3  2  60 
A8305H6  87  0  0  0 
Anti-lgG2b 
A4403A3  0  74  84  0 
A4401 F8  0  83  85  0 
A4403H6  0  83  89  0 
B2801DI 1  0  76  82  0 
80  94  96  94 
94  95  97  86 
68  93  94  75 
83  93  93  88 
89  88  92  88 
89  92  92  86 
83  94  96  92 
90  83  92  55 
89  90  96  94 
55  88  94  88 
61  92  96  93 
70  88  96  88 
8  75  83  9O 
17  3  8  0 
0  0  9  7 
9  0  0  0 
3  0  8  0 
* Culture supernatants were incubated for 1 h at 37°C with polystyrene 
then instrumentally  counted as described in Materials and Methods. 
*  Unlike anti-lgG2a RF, anti-IgG2a" RF do not bind to IgG2a  b. 
particles. Nonagglutinated particles were 
with IF1  did not bind to F(ab')~  fragments and therefore probably recognized 
determinants in the Cn2 domain. 
Determinants Recognized by Monoclonal IgG2a- and IgG2b-specific RF.  To localize 
the determinants recognized by anti-IgG2a and anti-IgG2b RF, we examined 
their binding to mutant proteins produced by variants derived from the MPC11 
('y2b, K) cell line. 
On  the  basis  of peptide maps,  charge,  and  assembly characteristics,  these 
mutant proteins fall into three groups (10).  Representatives of each group have 
been studied further by amino acid sequence analysis and nucleic acid studies (9, 
11-13). The structures of the heavy chain constant regions of the variant proteins 
used in the present work are schematically summarized in Fig. 1. 
The binding of 4 IgG2b-specific and 13 IgG2a-specific monoclonal RF to these 
variant proteins as well as to normal IgG2a and IgG2b was tested by agglutination 
of IgG-coated  polystyrene particles.  Anti-IgG2a  RF  included autoantibodies 1766  STASSIN ET  AL.  BRIEF  DEFINITIVE REPORT 
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FIGURE 2.  Localization  of the determinants recognized by polyclonal RF of MRL/1 (A), 
NZB/BinJ (0) and 129/Sv (O) mice. Inhibition of IgG2a- and IgG2b-specific RF by heat- 
aggregated IgG2a (MOPC173), IgG2b (MPC11), and IgG2b mutant proteins (M224, ICR 
4.68.110, and ICR 16). Appropriately diluted sera were incubated with inhibitors for 1 h at 
37°C before addition of polystyrene  particles coated with IgG2a (1103G4) or with IgG2b 
(308A8). Residual  agglutinations  were measured  as described in (7). 
directed against isotypic and allotypic determinants. The results shown in Table 
II indicate that most of these  RF reacted only in  the presence  of the proper 
segment between N-340 and the C-terminus. Of the  17 monoclonal RF tested, 
only  one  IgG2a-specific  RF  (A8305H6)  apparently  reacted  with  a  structure 
located in the CH2 domain or in the hinge region because it agglutinated particles 
coated with ICR16 but failed to react with ICR 11.19.3 or ICR 4.68.110. These 
results were confirmed by solid phase radioimmunoassay with IgG-coated wells 
(not shown). 
Determinants Recognized by Polyclonal IgG2a- and IgG2b-spec~c RF.  It was pre- 
viously shown that sera of autoimmune strains,  MRL/MpJ-lpr and NZB/BinJ, 
contain both  IgG2a- and  IgG2b-specific RF  (7). Because of the  simultaneous 
presence in these sera of anti-IgG2a and anti-IgG2b autoantibodies, it was not 
possible to map the antigenic determinants involved by direct binding or agglu- 
tination assays.  Competition experiments with heat-aggregated variant proteins 
were used  instead.  For  129/Sv  sera,  which lack  IgG2b-specific but have high 
titers of IgG2a-specific RF,  these experiments confirmed the data already ob- 
tained with monoclonal RF derived from this strain.  With MRL/MpJ-Ipr and 
NZB/BinJ  sera,  heat-aggregated  ICR  11.19.3  and  ICR  4.68.110  completely 
inhibited the agglutination of IgG2a-coated particles and not at all that of IgG2b- 
coated particles (Fig. 2). 
Discussion 
RF-like anti-IgG autoantibodies have now been detected in many species, but 
the determinants recognized by RF have so far only been mapped for human 
IgG.  Using  limited  digestion  of human  IgG  fragments  with  pepsin,  it  was STASSIN ET  AL.  BRIEF  DEFINITIVE REPORT  1767 
concluded that RF binding sites were distributed in both CH3 and CH2 domains 
(14). 
Previous attempts to localize the determinants recognized by mouse monoclo- 
nat RF by using papain fragments of various mouse IgG subclasses have met with 
little success, especially for anti-IgG1  RF. The latter, which represent the major 
form of RF produced after polyclonai activation, indeed failed to react with both 
IgG1  Fab or Fc fragments (5).  This observation led to the tentative conclusion 
that the determinants involved were located in the hinge region; however, in the 
absence of any positive identification, it was difficult to exclude the possibility 
that  conformational  changes  altering  determinants  located  elsewhere  in  the 
molecule were responsible for the observed lack of reaction with Fab and Fc. It 
seemed thus important to analyze the determinants involved in RF-IgG interac- 
tions with intact immunoglobulins. Variant immunoglobulins generated by mu- 
tagenic treatment of MPC 11 and carrying various hybrid 3"2a-3"2b heavy chains 
have been used before to determine which parts of the mouse 3,2b heavy chain 
react with  Fc receptors of macrophages and to localize allotypic determinants 
recognized by monoclonal alloantibodies (15,  16).  In the present experiments, 
these proteins permitted clear-cut mapping of the determinants recognized by 
IgG2a- and IgG2b-specific RF to a segment of the heavy chain spanning the C- 
terminal  eight  residues  of the  CH2  domain  and  the  complete  C,3  domain. 
Presence of a 3"2a sequence in this part of the heavy chain completely abolished 
all reactions with IgG2b-specific RF and was sufficient to optimally bind most 
IgG2a-specific RF, be they allotype-specific or not. 
Various spontaneous somatic mutants derived from the  MOPC21  myeloma 
cell  line have  extensively been  characterized  (9).  Two of them,  IF1  and  IF2, 
which lack the C.3 and C.I  domains of the 3'1  heavy chain, respectively, were 
of particular  interest  to  map  the  determinants  recognized  by  anti-IgG1  RF. 
These  variant  immunoglobulins  have  been  used  before  to  demonstrate  the 
importance of the Cu3  domain for the binding of IgG to mouse lymphocytes 
(17). Of 71 monoclonal IgG 1-specific RF obtained from 4 different strains under 
a variety of conditions including polyclonal activation in vivo or in vitro, only 1 
bound  to  IF1,  whereas  all  reacted  equally  well  with  IF2  and  normal  IgG1. 
Together  with  the  absence  of reaction  between  IgGl-specific  RF  and  IgG1 
F(ab')2  fragments,  these  observations  strongly  suggest  that,  like  IgG2a-  and 
IgG2b-specific RF, anti-IgG1  autoantibodies also preferentially recognize deter- 
minants located in the C-terminal region of the heavy chain. 
Summary 
The structures recognized by monoclonal anti-IgG1  rheumatoid factors (RF) 
were localized by testing their reactivity with mutant immunoglobulins carrying 
3'1 chains that lacked either the CH 1 or the C~3 domains. While optimal binding 
was observed in the absence of CH1, deletion of CH3  completely abolished the 
reactivity of all but one of the 71  monoclonal RF tested. 
Similar experiments were carried out with IgG2a- and IgG2b-specific RF by 
using variant immunoglobulins carrying various hybrid 3"2a-3"2b heavy chains. It 
was found that both the polyclonal RF produced by autoimmune strains, MRL/ 
MpJ-Ipr and NZB/BinJ,  and most of the monoclonal RF derived from normal 
strains,  BALB/c,  C57B1/6,  and  129/Sv,  were  directed  against  determinants 1768  STASSIN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
located in a segment spanning the C-terminal 8 residues of the CH2 domain and 
the complete CH3 domain. 
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